B7-H3 inhibits T-cell proliferation [23,24] and is associated with the inhibition of CD8+ T-cell upregulation, whereas aberrant B7-H3 expression is implicated in the elimination and dysfunction of CD8+ T-cell infiltration in head and neck cancer [25]. The gene discussed is CD276; the disease is head and neck cancer.